#oncology is an active hashtag on Bluesky. In the last 30 days, 110 people shared 377 posts with it — around 13 a day. Activity is up 3% versus the previous week, peaking on Aug 6 with 20 posts.
Tags most often used together with #oncology.
Dr. Jen Irwin @drjenirwin.bsky.social
“COVID-19 infection had a significant impact on patients with cancer, and risk factors for hospitalization and mortality were identified.” jamanetwork.com/journals/jam...
jamanetwork.com
Oncology starter pack
Starter pack by Rafael Santana-Davila
List of people with an interest in cancer medicine. Please suggest folks. For volume 2 go to https://go.bsky.app/UP8aWPd
people.com
Woman, 25, Dies Suddenly After Collapsing at Work: 'We're Still in Shock,' Her Employer Says
A 25-year-old woman died suddenly last weekend, weeks after collapsing at work and being diagnosed with leukemia and COVID-19. Samantha Kimene — who was from Ireland but was living in Tenerife, Spain,...
nej.md
Hemophagocytic Lymphohistiocytosis | NEJM
HLH, a cytokine-mediated hyperinflammation syndrome, causes fever, pancytopenia, and hemophagocytosis and is often fatal. Antiinflammatory agents, etoposide, and interferon-γ antibody are the main ...
buff.ly
Cancer hijacks your brain and steals your motivation − new research in mice reveals how, offering potential avenues for treatment
Cachexia, or wasting syndrome, causes around 80% of patients with advanced cancer to withdraw from life.
www.cell.com
EGFR-directed antibodies promote HER2 ADC internalization and efficacy
Gupta et al. demonstrate that high EGFR expression mediates resistance to HER2 antibody drug conjugates (ADCs) including trastuzumab deruxtecan (T-DXd) by limiting HER2/ADC internalization. The additi...
www.onclive.com
Dostarlimab Monotherapy Elicits Responses in First-Line PD-L1-Positive HNSCC | OncLive
Dostarlimab monotherapy produced a 27% response rate in PD-L1-positive recurrent/metastatic head and neck squamous cell carcinoma
www.onclive.com
Dr Thompson on 5-ARIs for Active Surveillance in Prostate Cancer | OncLive
Ian M. Thompson Jr, MD, MBA, discusses the potential role of 5-ARIs such as finasteride in prostate cancer.
www.onclive.com
Exploring the Rationale for 5-Alpha Reductase Inhibitors in Prostate Cancer Prevention and Active Surveillance | OncLive
lan M. Thompson Jr., MD, discusses the potential role of 5-ARIs for the treatment of patients with prostate cancer.
www.nbcwashington.com
Cancer cure or clickbait? An oncologist weighs in on ivermectin
It’s a controversial drug that was once touted as a cure for COVID-19 despite no evidence to show it actually worked. Now, prescriptions for ivermectin are soaring — this time for cancer. Some doctors...
www.onclive.com
Greater Flexibility and Improved QOL Represent Key Potential Benefits With Liquid TKI Formulations: With Jonathan Trent, MD, PhD | OncLive
Jonathan Trent, MD, PhD, discusses the clinically available TKIs for GIST and the potential benefits of liquid TKI formulations for this disease.
www.onclive.com
UCSF Cancer Researcher Awarded Prize for Early Career Scientists | OncLive
UCSF Health’s Adam Blaisdell, MD, PhD, has been selected as an IGNITE fellow by the Cancer Research Institute.
www.onclive.com
Dr Cohen on Future Research Avenues for Cevostamab in R/R Myeloma | OncLive
Adam D. Cohen, MD, discusses future research directions for cevostamab in relapsed/refractory multiple myeloma.
Posts are pulled live from Bluesky and cached briefly. Posts with content labels are hidden.
